Indeed, a study found that in 41% of primary breast cancer tumours investigated, the promoter of the ESR1 gene was hypermethylated, which strongly correlated with reduced ERα protein expression and more advanced disease (Ramos et al., 2010; Wei et al., 2012). The gene discussed is ESR1; the disease is breast carcinoma.